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Abstract
Background: Increased age is a major risk factor for stroke incidence, post-ischemic mortality, and severe and long-term
disability. Stroke outcome is considerably influenced by post-ischemic mechanisms. We hypothesized that the inflammatory
response following an ischemic injury is altered in aged organisms.
Methods and Results: To that end, we analyzed the expression pattern of pro-inflammatory cytokines (TNF, IL-1a, IL-1b, IL-
6), anti-inflammatory cytokines (IL-10, TGFb1), and chemokines (Mip-1a, MCP-1, RANTES) of adult (2 months) and aged (24
months) mice brains at different reperfusion times (6 h, 12 h, 24 h, 2 d, 7 d) following transient occlusion of the middle
cerebral artery. The infarct size was assessed to monitor possible consequences of an altered inflammatory response in aged
mice. Our data revealed an increased neuro-inflammation with age. Above all, we found profound age-related alterations in
the reaction to stroke. The response of pro-inflammatory cytokines (TNF, and IL-1b) and the level of chemokines (Mip-1a,
and MCP-1) were strongly diminished in the aged post-ischemic brain tissue. IL-6 showed the strongest age-dependent
decrease in its post-ischemic expression profile. Anti-inflammatory cytokines (TGFb1, and IL-10) revealed no significant age
dependency after ischemia. Aged mice brains tend to develop smaller infarcts.
Conclusion: The attenuated inflammatory response to stroke in aged animals may contribute to their smaller infarcts. The
results presented here highlight the importance of using aged animals to investigate age-associated diseases like stroke,
and should be considered as a major prerequisite in the development of age-adjusted therapeutic interventions.
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Introduction
In general, the interplay between the peripheral immune system and
the brain is well balanced in young organisms but becomes unfavorable
with ageing [1]. Impaired immune homeostasis in aged organisms is
associated with a decline in the ability to adapt to environmental stress.
The consequence of this is a significant higher vulnerability for diseases
and their impacts in the elderly. Stroke is the most common and most
important vascular disease of the cerebral nervous system. Cerebral
infarcts are the second leading cause of death worldwide and the
leading cause of adult disability. Increased age is a major risk factor for
stroke incidence, post-ischemic mortality, and severe and long-term
disability [2,3,4]. Although stroke is an extremely important health
issue, most pharmaceutical companies have terminated their research
programs due to the failure of previous studies [5]. One explanation for
the inability to transfer experimental results to the clinic may be the
predominant incorporation of young rodents in basic research. Several
initial indications that the response of the central nervous system to an
ischemic event is age dependent have been reported [6,7,8,9].
However, post-ischemic mechanisms are complex and more funda-
mental studies are required to understand the impact of age on these
processes.
Following cerebral ischemia, a cascade of inflammatory
mediators including cytokines (TNF, IL-1a, IL-1b, IL-6, IL-10,
TGFb1) and chemokines (MCP-1 [CCL2], Mip-1a [CCL3],
RANTES [CCL5]) is initiated. Cytokines and chemokines have
complex, overlapping and pleiotropic functions that may be both
beneficial and deleterious. The temporal expression profile of each
inflammatory mediator, its specific cell source and target, and their
coordinated interaction are important for stroke recovery. The
complex as well as dual role (beneficial versus deleterious) of the
inflammatory response to stroke has been extensively discussed
[10,11,12,13]. Ageing is associated with alterations of the cerebral
inflammatory system [14,15,16,17]. In particular, TNF, IL-1, and
IL-6 have been found to be increased with age [7,18]. The
inflammatory reaction of aged brains to cerebral injuries has
received little attention to date [19,20,21,22]. Indeed, the response
to stroke is currently unknown. It is assumed that the inflammatory
reaction influences the dimension of the injury [20]. Previous
studies investigating the infarct size in old mice have revealed
conflicting results; there are reports of increased, decreased or
similar infarct sizes in aged brains [8].
We hypothesized that the extent and the progression of the
immune response following an ischemic injury are altered in the
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26288elderly and that this age-dependent inflammatory reaction is a
determinantoftheoutcome followingstroke.Theaimofthe present
study was to systematically characterize the age-dependent changes
of the infarct size and the inflammatory response in an experimental
stroke model of mice. Transient occlusion of the middle cerebral
artery (MCAO) – a model that closely resembles human stroke [23]
– was used to induce cerebral infarction. The infarct size was
analyzed at three different reperfusion times up to 7 days. The
expression patterns of pro-inflammatory cytokines (TNF, IL-1a,
IL-1b, IL-6), anti-inflammatory cytokines (IL-10, TGFb1), and
chemokines (Mip-1a, MCP-1, RANTES) were investigated at
different reperfusion times (6 h, 12 h, 24 h, 2 d, 7 d).
Materials and Methods
All investigated mice were taken from a C57/BL6 inbred mice
strain, originally obtained from Jackson Laboratory, and randomly
assigned to the groups (described in more detail in Supplement
S1). Adult (2 months), middle-aged (9 months), and aged (15
months and 24 months) male native mice were used to investigate
age-related neuro-inflammation (n=4, each). The age-dependent
inflammatory response following induction of a cerebral infarct
(6 h, 12 h, 24 h, 2 d, and 7 d) was studied using adult (2 months)
and aged (24 months) mice that had undergone MCAO (n=4,
each). Infarct volumes were analyzed 2 h, 2 d, and 7 d after
MCAO (n=4, each). MCAO was performed as described
previously [24]. Briefly, a monofilament was introduced into the
internal carotid artery through an incision of the left common
carotid artery. In this position, the middle cerebral artery was
occluded for 30 min. Up to 7 d after reperfusion, the mortality
rates were 7% and 39% in adult and aged mice, respectively. The
effect of the surgical procedure was controlled using sham-
operated mice (n=4, each). These animals underwent anesthesia
and surgical procedures similar to the MCAO group but without
occlusion of the middle cerebral artery. In a pre-study, the cerebral
blood flow (CBF) was measured by laser Doppler flowmetry (LDF)
(Peri Flux System 5000, Perimed, Sweden) in adult (n=10) and
aged (n=9) mice. Rectal temperature was measured using the DC
Temperature Control System (FHC Inc., USA) in adult (n=6) and
aged (n=8) mice. Animals were maintained with access to water
and food ad libitum. All animal procedures were approved by the
local government (Thueringer Landesamt fu ¨r Lebensmittelsicher-
heit und Verbraucherschutz [TLLV], Dep.2, Gesundheitlicher
Verbraucherschutz, Veterina ¨rwesen, Pharmazie, Germany, Ap-
proval ID’s 02-20/05 and 02-028/10) and conformed to
international guidelines on the ethical use of animals. All surgeries
were performed under deep anesthesia (isoflurane).
Sample preparation
Infarct volumes were analyzed on Map2 immunostained slices
[2 h, 2 d, and 7 d after reperfusion, as described in detail by us
previously [25]]. Deeply anesthetized mice were fixed by perfusion
through the ascending aorta with 4% paraformaldehyde. Brains
were removed, cryoprotected in 0.2 M phosphate-buffered saline
containing 30% sucrose, and stored at 280uC. Coronal sections
(40-mm thick) were cut with a freezing microtome (MH400,
Microm International GmbH).
For mRNA and protein quantification, a separate group of mice
underwent MCAO. Animals were decapitated under deep
anesthesia and brains were removed at 6 h, 12 h, 24 h, 2 d, and
7 d. Using a Precision Brain Slicer (BS-2000C Adult Mouse,
Braintree Scientific Inc.), three coronal sections were dissected
cutting +2.8 and +0.8 mm to bregma (rostral slice), +0.8 and
21.2 mm to bregma (middle slice), and 21.2 and 23.2 mm to
bregma (caudal slice). The ipsilateral (ischemic tissue) and
contralateral (non-ischemic tissue) hemispheres of the middle
brain slice were separated and snap-frozen (for details see
Supplement S1). Adjacent slices were used for infarct validation
(Map2 immunohistochemistry), to select mice with similar lesion
size for mRNA and protein quantification.
Tissue samples of native mice (right hemisphere, +0.8 and
21.2 mm to bregma) were used to study the age-related cerebral
inflammation.
For quantitative PCR (qPCR), tissue samples were homoge-
nized in 1 ml QIAzol Lysis Reagent and total RNA was isolated
using the RNeasy Lipid Tissue Mini Kit (Qiagen GmbH). For
cytokine bead assay (CBA), tissue samples were homogenized in
400 ml ice-cold lysis buffer (0.32 M sucrose; 4 mM Tris-HCl,
pH 7.4; 1 mM EDTA; and 0.25 mM dithiothreitol) containing
protease inhibitors Complete Mini (Roche) and proteins were
isolated as previously described [26].
Immunohistochemistry (Map2)
Free-floating sections (cerebrum, 40 mm thick) were incubated
at 4uC overnight with antibody against Map2 (monoclonal mouse
anti-MAP2 (2a+2b), clone AP-20, Sigma-Aldrich, 1:1,000), then
further processed by the Vectastain Elite ABC Kit (Vector
Laboratories) using a biotinylated secondary antibody (donkey
anti-mouse, Dianova, 1:500). Immunoreactivity was developed in
3,39-diaminobenzidine tetrahydrochloride (DAB; Sigma).
qPCR
For qPCR, equal amounts of total RNA (1 mg) were transcribed
in cDNA with RevertAid First Strand cDNA synthesis kit
(Fermentas [27]). Amplification products were analyzed using gel
electrophoresis, melting curve analysis, and sequencing to confirm
the PCR product specificity. PCR was performed in a volume of
20 ml containing BrilliantH II SYBR GreenH qPCR Master Mix
(Stratagene), cDNA (equivalent to 25 ng reverse transcribed
RNA), and specific primers (Table 1) each at a final concentration
of 500 nM. Amplification was performed using the Rotor-Gene
6000 (Corbett Life Science) applying the following cycle
conditions: 10 min polymerase activation, 40 amplification cycles
(95uC for 30 s, 60uC for 30 s, 72uC for 30 s), and melting curve.
Cytokine bead assay (CBA)
The protein expression pattern was measured by a CBA with
TNF, IL-1a, IL-1b, IL-6, IL-10, Mip-1a, MCP-1, and RANTES
mouse Flex Sets (BD Bioscience). No antibody was available for
TGFb1. The procedure was performed according to the
manufacturer’s instructions with the following modifications. To
ensure a valid analysis of proteins below 10 pg/ml (the default
outlined limit for quantification), (i) 300 mg whole protein was
dissolved in 50 ml lysis buffer, (ii) the standard curve was
constructed from 1.25–156 pg/ml (dissolved in lysis buffer), and
(iii) samples as well as standards were washed twice at the end of
the procedure to reduce background signals. Standards and test
samples were analyzed using the Cytomics FC500 Flow Cytom-
etry System (Beckman Coulter) with its settings optimized to
ensure valid quantifications even for proteins present in very low
amounts.
Data analysis
qPCR. External standard curves of purified PCR products
(five 10-fold dilution series) were applied for absolute
quantification, as described previously [27]. The numbers of
transcripts were calculated per 1,000 transcripts of Gapdh by
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Hmbs was used as a second internal standard. Both Gapdh and
Hmbs were stably expressed under the conditions of investigation.
CBA. The rawdata from the Cytomics FC500 Flow Cytometry
System were analyzed using FCAP Array
TM software (SoftFlow).
Protein concentrations of the test samples were calculated using a
corresponding standard curve (supplied recombinant protein with
known concentration).
Statistical analysis
Differences between the infarct volumes of adult (2 months) and
aged (24 months) mice at different time points (2 h, 2 d, and 7 d)
were analyzed with ANOVA and post-hoc Tukey test. Significant
differences of mRNA and protein expression values dependent on
ageing per se (versus 2-month-old controls) were calculated with
ANOVA and post-hoc Tukey test (& p#0.05, && p#0.01, &&&
p#0.001). Correlation of the expression level with age (R, Pearson
correlation) is indicated by + p#0.05, ++ p#0.01, and +++
p#0.001. Significant post-ischemic differences of the expressions
levels (ipsi versus contra) at several time points (6 h, 12 h, 24 h,
2 d and 7 d) were calculated with paired two-way ANOVA and
post-hoc Tukey test. Analyses were done separately for adult
(* p#0.05, ** p#0.01, *** p#0.001) and aged (# p#0.05, ##
p#0.01, ### p#0.001) mice. Significant age-dependent differ-
ences of absolute expression within the ipsilateral hemisphere were
calculated within a further two-way ANOVA and are displayed by
{ p#0.05, {{ p#0.01, {{{ p#0.001. All tests were performed with
SigmaStat (software version 3.5).
Results
Almost all the tested inflammatory mediators showed increased
expression values during ageing per se. The pro-inflammatory
cytokines, particularly TNF, as well as the chemokines Mip-1a and
MCP-1 showed a distinct up-regulation with age. Following stroke,
the expression of almost all the tested inflammatory mediators was
significantly up-regulated in ischemic tissues. However, a clearly
attenuated inflammatory response was apparent in aged brains
following the ischemic insult. TNF, IL-1a, IL-1b, IL-6, Mip-1a,
and MCP-1 displayed an age-related decreased post-ischemic
expression, with IL-6 exhibiting the strongest decrease. Aged mice
brains also exhibited smaller infarcts. The sham procedure had no
substantial effect on the expression of all the tested cytokines and
chemokines. No significant differences of the cerebral blood flow
and the body temperature were observed between adult and aged
mice during or after MCAO (data not shown).
Infarct volume
Occlusion of the middle cerebral artery for 30 min led to an
ischemic injury mainly restricted to striatal regions of the mice
brains. At different reperfusion times (2 h, 2 d, and 7 d) the infarct
size tend to be smaller in aged mice. Taking all time points
together, the mean infarct volume of aged mice was significantly
smaller (Figure 1, Map2 immunohistochemistry, ANOVA with
post-hoc Tukey test, p#0.05).
Pro-inflammatory cytokines TNF, IL-1a, and IL-1b
All the tested major pro-inflammatory cytokines were signifi-
cantly elevated with ageing per se regarding their mRNA level
(TNF 5-fold, p#0.01; IL-1a ,1.9-fold, p#0.05; IL-1b ,2.4-fold,
p#0.01; Figure 2). This up-regulation was reflected in the level of
protein, though it was not as pronounced (TNF 1.1-fold, n.s.; IL-
1a 1.1-fold, n.s.; Figure 2).
Following ischemia in adult mice brains, the transcript
expression of all the tested pro-inflammatory cytokines was clearly
elevated (TNF up to 61-fold, p#0.001; IL-1a up to 13-fold,
p#0.01; IL-1b up to 37-fold, p#0.001; Figure 2). This massive
inflammatory response in adult ischemic brains was markedly
attenuated in aged brains (by 41% for TNF; by 68% for IL-1a;b y
79% for IL-1b).
The up-regulation of TNF mRNA and protein peaked at 12 h
after reperfusion in adult mice (mRNA 56-fold, protein 2.3-fold;
p#0.001). The TNF protein level in aged mice brains following
stroke showed an elevated expression but was not significantly
affected. The extent of the post-ischemic response was approxi-
mately the same for IL-1a mRNA and protein, but a delayed peak
expression of IL-1a protein was observed (mRNA peak at 6 h,
protein peak at 12 h after reperfusion). The protein level of IL-1b
could not be reliably quantified (data not shown).
Cytokine IL-6
The increased IL-6 mRNA level significantly correlated with
age (Pearson, p#0.05), though this was not reflected in its protein
level (Figure 3). The post-ischemic IL-6 expression of adult mice
was up-regulated by up to 69-fold for its mRNA level (peak at 12 h
after reperfusion, p#0.001) and by up to 11-fold for its protein
level (peak at 24 h after reperfusion, p#0.001; Figure 3). The
ischemic response in aged brains was attenuated by 82% at the
transcript level (at 12 h) and by 85% at the protein level (at 24 h).
In adult mice, the mRNA expression of IL-6 increased from 6 h to
12 h when it reached its peak expression. In aged mice, IL-6
mRNA expression peaked at 6 h and then displayed a rapid decay.
Table 1. Primer sequences.
Primer Sequence (59R39)
GenBank
accession number
Gapdh forward CAACAGCAACTCCCACTCTTC NM_008084.2
Gapdh reverse GGTCCAGGGTTTCTTACTCCTT
Hmbs forward GAAATCATTGCTATGTCCACCA NM_013551.2
Hmbs reverse GCGTTTTCTAGCTCCTTGGTAA
TNFa forward GTCTACTGAACTTCGGGGTGAT NM_013693.2
TNFa reverse ATGATCTGAGTGTGAGGGTCTG
IL-1a forward GCCTTATTTCGGGAGTCTAT NM_010554.4
IL-1a reverse TAGGGTTTGCTCTTCTCTTACA
IL-1b forward GAAGAGCCCATCCTCTGTGA NM_008361.3
IL-1b reverse TTCATCTCGGAGCCTGTAGTG
IL-6 forward ACAAAGCCAGAGTCCTTCAGAG NM_031168.1
IL-6 reverse CATTGGAAATTGGGGTAGGA
IL-10 forward ATGGTGTCCTTTCAATTGCTCT NM_010548.1
IL-10 reverse AGGATCTCCCTGGTTTCTCTTC
TGFb1 forward TGCTTCAGCTCCACAGAGAA NM_011577.1
TGFb1 reverse TACTGTGTGTCCAGGCTCCA
Mip-1a forward TGGAACTGAATGCCTGAGAGT NM_011337.2
Mip-1a reverse TAGGAGATGGAGCTATGCAGGT
MCP-1 forward AGGTGTCCCAAAGAAGCTGTAG NM_011333.3
MCP-1 reverse AATGTATGTCTGGACCCATTCC
RANTES forward CCAGAGAAGAAGTGGGTTCAAG NM_013653.2
RANTES reverse AAGCTGGCTAGGACTAGAGCAA
The GenBank accession numbers were obtained from the NCBI (March 2010).
doi:10.1371/journal.pone.0026288.t001
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TGFb1 transcript levels correlated significantly with age
(Pearson, p#0.05; Figure 3). In contrast to all the other tested
cytokines, the post-ischemic TGFb1, expression increased contin-
uously with time (up to 7 d) in adult and aged brains (4.5-fold and
2.5-fold, respectively; p#0.001). However, the up-regulation of
TGFb1 was attenuated in aged mice by 33% (7 d after
reperfusion; Figure 3).
The expression of IL-10 mRNA tended to be elevated during
ageing per se, but it was not significantly up-regulated (1.5-fold,
n.s.; Figure 3). Following stroke, the IL-10 transcript expression
peaked at 6 h after reperfusion for both ages of mice (2.1-fold,
adult p#0.05, aged p#0.01). The post-ischemic IL-10 mRNA
response was not found to be significantly altered in aged brains
(Figure 3).
The protein expression of IL-10 and TGFb1 could not be
validated. The IL-10 protein levels in the test samples have been
found below the sensitivity of the BD Bioscience Flex Set. In the
case of TGFb1, an appropriate antibody was not provided by the
BD Bioscience Flex Set.
Chemokines Mip-1a, MCP-1, and RANTES
The transcript levels of all the tested chemokines increased with
ageing per se. The strongest increase was observed for Mip-1a
mRNA (3.5-fold, p#0.001; Figure 4) and MCP-1 mRNA (3.6-
fold, p#0.001; Figure 4). The protein levels of Mip-1a and
RANTES correlated significantly with age (Pearson, p#0.01 and
p#0.05, respectively; Figures 4 and 5). The protein level of MCP-
1 tended to be increased; however, it failed to reach significance
(Figure 4).
Mip-1a mRNA expression peaked 12 h after ischemia in adult
mice (Figure 4). Aged mice displayed a significant attenuated
response of Mip-1a transcript expression at 12 h after reperfusion
(by 55%) and over all time points (by 33%). This post-ischemic
diminished Mip-1a response was observed to be less pronounced
at the protein level (by 25%, n.s.).
The transcript expression of MCP-1 peaked at 12 h after
ischemia in adult mice brains (up to 102-fold, p#0.001; Figure 4).
However, this strong response was significantly attenuated in aged
mice brains (up to 57%). The post-ischemic protein expression
peaked at 12 h and 24 h in aged and adult mice brains,
respectively (up to 9-fold, adults, p#0.001). MCP-1 mRNA
response seems also be attenuated, in aged mice brains (by 48%,
24 h after reperfusion).
The expression of RANTES mRNA increased continuously up
to 7 d following ischemia in adult brains (3.5-fold, p#0.001;
Figure 5). Aged brains showed no obvious post-ischemic increase
in RANTES transcript expression in the ipsilateral hemisphere;
however, the contralateral hemisphere displayed a decrease
(Figure 5). Therefore, the ratio of ipsilateral versus contralateral
RANTES mRNA resulted in a significant ischemic effect
(Figure 5). The level of RANTES protein peaked at 24 h after
reperfusion. RANTES did not display a significant age-dependent
post-ischemic response (Figure 5).
Discussion
We found profound age-related alterations in the reaction to
stroke. The response of pro-inflammatory cytokines and the level
of chemokines were strongly diminished in the aged post-ischemic
brain tissue (summarized in Figure 6). Anti-inflammatory cytokines
(TGFb1, and IL-10) revealed no significant age dependency after
ischemia. In concordance, the mean infarct volume of aged mice
brains was found to be smaller.
Age dependence of infarct size
Previous studies reported contradictory results on the age
dependence of stroke size. Most studies found no age dependence
or rather smaller infarct sizes, in experimental [28,29,30] as well as
in clinical [31,32] observations. Larger stroke sizes in aged animals
were reported after permanent MCAO at early times (6 h [33],
24 h [34], and 3 d [35]) while this was not observed at later times
(7 d [35]), indicating that the dynamics of stroke development
following permanent MCAO might be different in aged animals.
Stroke size might also depend on the gender of aged animals
and the hormone level. Female aged rodents had larger infarcts
whereas ovariectomized rats had smaller infarcts [36,37]. Alto-
gether, our result of a tendency to smaller infarcts in aged mice
following transient MCAO is in agreement with most of the
previous experimental studies [28,29,30] and in line with clinical
observations [31,32].
Elevated cerebral inflammation with age
The expression levels of inflammatory mediators in the brain
are low due to the immune privilege of the central nervous system
Figure 1. Infarct volumes at different ages. The mean infarct volume
(6SEM) was significantly smaller in aged mice brains (Map2 immunohisto-
chemistry, ANOVA with post-hoc Tukey test, * p#0.05).
doi:10.1371/journal.pone.0026288.g001
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guarantee high sensitivity [27]. Protein expression was determined
by flow cytometry with a bead-based immunoassay to minimize
technical variations and to guarantee a high performance of each
antibody in a multiplex scenario.
With the systematic approach used in this study, we showed that
baseline expression levels of all the tested inflammatory mediators
increased with age. Transcripts of the pro-inflammatory cytokines
IL-1a, IL-1b, IL-6, and notably TNF as well as transcripts of the
chemokines Mip-1a, MCP-1, and RANTES were up-regulated.
Moreover, we found increased levels of the anti-inflammatory
cytokines IL-10 and TGFb1, with the transcript of TGFb1
exhibiting the more prominent increase with age. These data are
in agreement with the findings of previous studies, which reported
similar tendencies for selected inflammatory mediators using
different techniques [7,9,17,18,39]. With the exception of IL-6
and MCP-1, the protein expression of the inflammatory mediators
increased with age, similar to their mRNA profiles. Although
several methodological precautions were applied, the physiological
protein levels were at (IL-6 and MCP-1) or below (IL-1b and
IL-10) the limit of quantification. As mentioned above, an
appropriate TGFb1 antibody was not available.
Attenuated inflammatory response after ischemic injury
in aged brains
The post-ischemic response of the pro-inflammatory cytokines
TNF, IL-1b, and particularly IL-6 as well as of the chemokines
Mip-1a and MCP-1 was significantly attenuated in aged brains.
The anti-inflammatory capacity (TGFb1, and IL-10) revealed no
significant age related differences after ischemia.
In line with our findings, an attenuated inflammatory response
in aged brains was also observed following NMDA-induced brain
injury (striatal TNF and cortical IL-1b [7]) or after whole brain
irradiation (hippocampal TNF, IL-1b, IL-6, and MCP-1 [40]). In
contrast, elevated pro-inflammatory reactions were observed in
aged brains after mechanical injuries [9,41], intracerebral
hemorrhage [42], or ischemia [43]. Therefore, post-injury infla-
mmatory mechanisms do not follow a general pattern, but appear
to depend on the type and extent of stimulation.
Potential reasons for the age-related attenuated post-
ischemic inflammatory response
Elevated pro-inflammatory cytokine levels in aged brains may
mediate a kind of preconditioning similar to the situation where
administration of low levels of TNF and IL-1 leads to ischemic
tolerance [44,45]. In such a scenario, greater levels of stimulation
would be required to induce a comparable inflammatory response.
However, if and to what extent the attenuated post-ischemic
immune response is due to elevated baseline levels of pro-
inflammatory cytokines in aged brains cannot be determined from
our results.
IL-6 exhibited the strongest decrease in its expression profile
following stroke in aged mice brains. IL-6 is a pleiotropic cytokine
that coordinates inflammatory processes between the periphery
and the central nervous system, and can be released by various cell
types in response to injuries. Moreover, IL-6 influences the
expression and function of several other inflammatory mediators.
Therefore, IL-6 may be a key mediator of the reduced infla-
mmatory reaction following stroke in aged mice.
Similar to IL-6, all the other tested inflammatory mediators
interact with each other. TNFa, for instance, influences several
other inflammatory mediators, e.g. IL-6 and IL-1b [46,47]. Also,
IL-1b can stimulate cells to express MCP-1 [48]. Conversely,
MCP-1-deficient mice express less IL-1b after permanent MCAO,
indicating a signaling in both directions [49]. Therefore, a down-
regulation of some of the key players of the post-stroke immune
response may subsequently lead to a general reduction of the
involved inflammatory mediators.
Potential functional consequences of an attenuated
inflammatory response
Pro-inflammatory cytokines are generally considered to mediate
detrimental effects following ischemia. Administration of TNF or
IL-1 exacerbates damage [19,50], and inhibition of TNF or IL-1
as well as IL-1 deficiency lead to reduced ischemic injuries [19].
IL-6 as a pleiotropic mediator can potentially exert detrimental
(early phase) or beneficial effects (late phase) following ischemia.
Post-ischemic injection of recombinant IL-6 mediates neuropro-
tection and reduces the injury, whereas administration of anti-
mouse IL-6 receptor monoclonal antibody or the use of IL-6-
knockout mice increases infarct size [51].
Anti-inflammatory cytokines such as TGFb1 and IL-10 have a
beneficial function after ischemia. IL-10 deficiency exacerbates
damage, whereas its over-expression reduces infarct volumes after
ischemic brain injury [52]. Both of these anti-inflammatory
cytokines are able to block NF-kappa B activation and thereby
the expression of transcripts involved in immune and inflamma-
tory responses [53,54].
CC chemokines or b-chemokines recruit immune competent
cells to injured tissue [55]. Studies which inhibited MCP-1 in the
rat brain or used MCP-1-deficient mice reported smaller ischemic
lesions, whereas over-expression exacerbated damage [19]. Inhi-
bition of MCP-1 and Mip-1a signaling leads to reduced infarct
volumes following MCAO [56]. In concordance, the administra-
tion of Mip-1a has been found to increase the infarct volume [56].
RANTES-deficient mice exhibited decreased leukocyte adhesion,
diminished blood-brain barrier permeability, and less tissue
infarction [57].
The present study has revealed an attenuated response of
inflammatory mediators in aged brains following stroke. More-
over, we observed smaller infarcts in aged brains. Most studies in
rodents as well as in humans have reported that cerebral infarcts
in aged organisms are not different from those in adults [8].
The smaller infarcts in aged brains observed here could be a
consequence of the diminished pro-inflammatory response. This
hypothesis is in line with the literature which reports a detrimental
effect of pro-inflammatory cytokines and chemokines on the extent
of injuries (as outlined above). The attenuated expression of IL-6
Figure 2. Age- and stroke-dependent expression of TNF, IL-1a, and IL-1b. TNF, IL-1a, and IL-1b displayed significantly elevated expression
levels with age. All these pro-inflammatory cytokines showed a distinct response following stroke, which was attenuated in aged brains. Expression
values are shown as mean 6 SEM and ratios as geometric mean 6 SEM. Significant age-related differences (versus 2-month-old native mice) are
indicated by & p#0.05, && p#0.01, and &&& p#0.001 (ANOVA and post-hoc Tukey test). Correlation of the cytokine expression level with age is
indicated by + p#0.05, ++ p#0.01, and +++ p#0.001 (R, Pearson correlation). Significant post-stroke differences (ipsi versus contra) are indicated by
adult: * p#0.05, ** p#0.01, and *** p#0.001; and aged: # p#0.05, ## p#0.01, and ### p#0.001 (paired two-way ANOVA and post-hoc Tukey
test). Significant age-dependent differences after stroke (ipsi aged versus ipsi adult) are displayed by { p#0.05, {{ p#0.01, and {{{ p#0.001 (two-
way ANOVA).
doi:10.1371/journal.pone.0026288.g002
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PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26288Figure 3. Age- and stroke-dependent expression of IL-6, TGFb1 and IL-10. IL-6 transcript expression significantly correlated with age;
however, this correlation was not reflected in the expression of its protein. The post-ischemic IL-6 response was attenuated in aged brains (mRNA and
protein). TGFb1 mRNA significantly correlated with age. IL-10 mRNA tended to be elevated in aged brains. TGFb1 transcript expression in the
ischemic tissue increased continuously with reperfusion time at both ages. The up-regulation of TGFb1 and IL-10 following ischemia tended to be
attenuated in aged brains. Expression values are shown as mean 6 SEM and ratios as geometric mean 6 SEM. For details of the statistical analysis,
see Figure 2’s legend or the Materials and Methods section.
doi:10.1371/journal.pone.0026288.g003
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PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26288Figure 4. Age- and stroke-dependent expression of Mip-1a and MCP-1. Mip-1a and MCP-1 displayed significantly elevated expression levels
with age. Mip-1a and MCP-1 transcript and protein expression increased significantly following stroke. This up-regulation was attenuated in aged
brains. Expression values are shown as mean 6 SEM and ratios as geometric mean 6 SEM. For details of the statistical analysis, see Figure 2’s legend
or the Materials and Methods section.
doi:10.1371/journal.pone.0026288.g004
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PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e26288Figure 6. Schematic diagram summarizing the post-ischemic expression profiles of all the tested inflammatory mediators. The
relative expression profiles (%) of all the tested inflammatory mediators in adult (continuous line, colored area) and aged brains (dotted line, light
colored area) are shown (mRNA, left panel; protein, right panel). The post-ischemic response of TNF, IL-1a, IL-1b, IL-6, Mip-1a, MCP-1, and TGFb1 was
considerably attenuated with age, with IL-6 exhibiting the strongest age-dependent effect.
doi:10.1371/journal.pone.0026288.g006
Figure 5. Age- and stroke-dependent expression of RANTES. The expression of RANTES significantly correlated with age. After ischemia, the
level of RANTES mRNA continuously increased up to 7 d in adult brains, whereas no up-regulation was observed in aged brains. Protein levels of
RANTES were up-regulated in adult and aged brains. Expression values are shown as mean 6 SEM and ratios as geometric mean 6 SEM. For details of
the statistical analysis, see Figure 2’s legend or the Materials and Methods section.
doi:10.1371/journal.pone.0026288.g005
Age-Dependent Post-Ischemic Inflammation
PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e26288in aged post-ischemic brains may be harmful in the late ischemic
phase.
Conclusions and future perspectives
From a theoretical point of view, attenuated post-lesional levels
of pro-inflammatory cytokines and chemokines may be considered
as a neuroprotective mechanism in aged brains. The smaller
infarcts in aged brains could potentially be a consequence of this
neuroprotection. However, reasons for the attenuated age-related
stroke response cannot yet be specified. Increased baseline
inflammation in aged brains may influence post-ischemic
inflammatory processes. Modulation of the age-related neuro-
inflammation (e.g. by pharmacological intervention or physical
activity) with subsequent stroke induction would provide an
opportunity to clarify this issue. Furthermore, investigations
involving aged transgenic mice with altered inflammatory brain
responses are necessary to unravel the functional relevance of our
findings.
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